Scarica l'app Stockscreener
142.85
1.09%
-1.57
Dopo l'orario di chiusura:
142.40
-0.45
-0.32%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BX Giù?
Forum
Previsione
Storia dei dividendi
Blackstone Inc Borsa (BX) Ultime notizie
Blackstone president says businesses should worry about AI disruption - Nikkei Asia
Private Equity Must Sell More Assets — at Whatever Price - Bloomberg
Blackstone-Backed Food Sanitation Cleaner Inks Workout Deal - Bloomberg
Blackstone scores rare premium in Boston office building sale - The Business Times
Blackstone Scores Rare Premium in Boston Office Building Sale - Bloomberg
Despite payout cut, Blackstone BDC 'expects' a strong November, president Jonathan Gray says - InvestmentNews
Sector Update: Health Care Stocks Rise Late Afternoon - MarketScreener
Private Credit Dealmakers Face Years of Heavy Lifting in Japan - Bloomberg
The Every Company's Series D, Apollo's $6.5b wind farm bet, and Blackstone invests in Merck - Axios
Key facts: Blackstone reports $54.2B inflows; to acquire Hologic for $18.3B; buys stake in TriMas for $1.45B - TradingView
SEI gatekeepers drop T. Rowe for Blackstone on $3.2bn high-yield strategy - Citywire
Merck & Co. secures $700M from Blackstone to fund lead ADC sac-TMT - FirstWord Pharma
Merck Entering $700 Million R&D Funding Agreement With Blackstone Life Sciences - Pulse 2.0
Blackstone $1.45bn CMBS oversubscribed - GlobalCapital
Royalty Pharma Buys Royalty Interest in Alnylam Pharmaceuticals' Amvuttra From Blackstone Life Sciences for $310 Million - MarketScreener
Bain Lines Up $3.1 Billion Private Loan for Service Logic Buy - Bloomberg
Merck & Co Receive $700 Million From Blackstone to Boost Cancer Drug Development - USA Herald
Blackstone Injecting $700M Into Merck Cancer Therapy - Law360
Merck secures $700 million funding from Blackstone to develop cancer therapy - Reuters
Earnings call transcript: Black Stone Minerals Q3 2025 beats expectations - Investing.com
Private equity powering AI boom at public cost - Private Equity Stakeholder Project PESP
Merck & Blackstone Enter Research and Development Funding Agreement - Contract Pharma
Blackstone-backed Nexus Select Trust eyes multiple mall acquisitions - livemint.com
Merck strikes financing agreement with Blackstone - MarketScreener
Merck to Receive $700 Million From Blackstone Unit to Support Experimental Cancer Drug Development - MarketScreener
Merck writes tale of 2 checks, bagging $700M from Blackstone and spending $150M to regain asset - Fierce Biotech
Merck (MRK) Secures $700M from Blackstone for Cancer Therapy Dev - GuruFocus
Merck clinches $700 million from Blackstone to develop ADC for cancer - PharmaLive
TriMas Enters Into Agreement to Sell TriMas Aerospace for $1.45 Billion - Yahoo Finance
Merck to receive $700M from Blackstone to develop cancer therapy - MSN
Merck inks $700M deal with Blackstone for cancer drug (MRK) - Seeking Alpha
Blackstone (BX) Invests in Merck's Cancer Treatment Development - GuruFocus
Corton Capital Inc. Invests $327,000 in Blackstone Inc. $BX - MarketBeat
Blackstone to pay Merck $700M to fund development of antibody-drug conjugate - Endpoints News
Wellington Shields Capital Management LLC Grows Stake in Blackstone Inc. $BX - MarketBeat
Royalty Pharma (NASDAQ: RPRX) acquires 1% AMVUTTRA royalty for $310M from Blackstone - Stock Titan
Merck secures $700 million from Blackstone to fund cancer drug development - Investing.com
Blackstone pays Merck $700M to buy into ADC drug royalties - Yahoo Finance
Merck, Blackstone Life Sciences sign R&D funding deal for sacituzumab tirumotecan (sac-TMT) - MarketScreener
Merck and Blackstone enter research agreement to develop cancer therapy for $700 million - MarketScreener
Ex-Blackstone, Partners Group Execs Raise $1.1B for APAC Real Estate Secondaries - Mingtiandi
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT) - MarketScreener
Merck receives $700 million from Blackstone for cancer drug development - StreetInsider
Bank of New York Mellon Corp Sells 288,843 Shares of Blackstone Inc. $BX - MarketBeat
FERC urged to reject Blackstone’s New Mexico utility takeover - Southwest Ledger
Royalty Pharma acquires royalty stake in Alnylam’s Amvuttra from Blackstone for $310m - pehub.com
Blackstone Inc. $BX Shares Sold by Freestone Capital Holdings LLC - MarketBeat
Bank of Montreal Can Lowers Stock Holdings in Blackstone Inc. $BX - MarketBeat
Blackstone’s Gray: We may seek faster exits to avoid AI disruption risk - Private Equity International | PEI
Could Blackstone’s (BX) Moves in Europe and Retirement Markets Redefine Its Competitive Edge? - simplywall.st
Blackstone Mortgage Trust, Inc. (BXMT) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Blackstone VP and Progress Together CEO to address female leaders at FN event - Financial News London
Blackstoneissues $1.2 billion in senior notes due 2030 and 2036SEC filing - MarketScreener
Hologic Tops Expectations And Receives Buyout Offer From Blackstone - Finimize
Blackstone Group Completes $1.2 Billion Senior Notes Offering - TipRanks
Blackstone completes $1.2 billion senior notes offering - Investing.com
Blackstone Completes Senior Notes Offering - The Joplin Globe
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2025 - Stock Titan
News | Blackstone secures $1.45 billion CMBS loan for 94-property industrial portfolio - CoStar
Rethinking the 60% - Blackstone
Hedge Fund and Insider Trading News: Scott Bessent, Ray Dalio, Warren Buffett, D.E. Shaw, Davidson Kempner, Millennium Management, Blackstone Inc (BX), Service Corporation International (SCI), and More - Insider Monkey
Blackstone appoints head of CLOs - Pensions & Investments
Leonard Green Is Leading a $1 Billion Ares Continuation Fund - Bloomberg
Blackstone firm launches $3bn Saudi data centre venture - Global Construction Review
Sunday’s Insider Moves: Top Execs Make Million-Dollar Trades on Friday - Investing.com
Published on: 2025-11-03 07:41:11 - newser.com
Why Is Blackstone Stock Falling? - Forbes
0.56%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):